Form 4 for HQL abrdn Life Sciences Investors
Accepted 2025-03-31 00:00:00 ET · period of report 2025-03-27 · accession 0001510281-25-000174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-03-31 | 2025-03-27+ | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $13.00 | -36.5K | 3.24M | -1% | -$475.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-28 | S | D | 3,602 | $12.95 | 3,237,028 | I - | — | — | |
| 2 | Common | Common Stock | 2025-03-27 | S | D | 32,922 | $13.01 | 3,240,630 | I - | — | — |